NovaBay Pharma (NBY) Posts Wider than Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
GEHC, NPK, HOS, More
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
GEHC, NPK, HOS, More
Join SI Premium – FREE
NovaBay Pharmaceuticals, Inc. (AMEX: NBY) reported Q1 loss of ($0.08), $0.03 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.22 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OneSpaWorld Holdings Ltd. (OSW) Tops Q3 EPS by 3c ; Offers Guidance
- NiSource (NI) Tops Q3 EPS by 5c ; Offers Guidance
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
